You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Psychosomatic diagnostics and therapy are of increasing importance in the acute treatment, prevention and rehabilitation of cardiovascular diseases. The connection between heart disease and the psyche as well as the psychosocial concomitant symptoms is well documented. Contents: • Basics of cardiology and psychosomatic medicine; • Doctor-patient relationship; • Ethical issues, gender effects, psychocardiology along the lifespan; • Psychosomatic problem areas and comorbidities in coronary heart disease: Personality factors, risk behaviours, depression, anxiety disorders; • Specific problems in other cardiovascular diseases and treatment settings; • Diagnostics; • Interdisciplina...
Die psychosomatische Diagnostik und Therapie hat eine zunehmend wichtige Bedeutung bei der Akutbehandlung, Prävention und Rehabilitation kardiovaskulärer Erkrankungen. Der Zusammenhang zwischen Herzerkrankungen und Psyche sowie den psychosozialen Begleiterscheinungen ist gut belegt. Grundlagen der Kardiologie und psychosomatischen Medizin Arzt-Patienten-Beziehung Ethische Fragestellungen, Gendereffekte, Psychokardiologie entlang der Lebensspanne Psychosomatische Problemfelder und Komorbiditäten Ursachen und Folgen: Persönlichkeitsfaktoren, Risikoverhalten, Depression, Angststörungen ... Spezifische Diagnostik und Behandlungskonzepte – ambulant und stationär Interdisziplinäre Zusamme...
Abstract: Background The EQ-5D and the SF-6D are examples of commonly used generic preference-based instruments for assessing health-related quality of life (HRQoL). However, their suitability for mental disorders has been repeatedly questioned. Objective To assess the responsiveness and convergent validity of the EQ-5D-3L and SF-6D in patients with depressive symptoms. Methods The data analyzed were from cardiac patients with depressive symptoms and were collected as part of the SPIRR-CAD (Stepwise Psychotherapy Intervention for Reducing Risk in Coronary Artery Disease) trial. The EQ-5D-3L and SF-6D were compared with the HADS (Hospital Anxiety and Depression Scale) and PHQ-9 (Patient Healt...
None